Allogene Therapeutics, Inc. (ALLO)

NASDAQ: ALLO · Real-Time Price · USD

1.130

-0.040 (-3.42%)

At close: May 13, 2025, 4:00 PM

1.099

-0.031 (-2.74%)

Pre-market: May 14, 2025, 9:01 AM EDT

Allogene Therapeutics Market Cap

Allogene Therapeutics has a market cap or net worth of $247.17 million as of May 14, 2025. Its market cap has decreased by -49.90% in one year.

Market Cap

247.17M

Enterprise Value

48.41M

1-Year Change

-49.90%

Ranking

#3474

Market Cap Chart

Since October 11, 2018, Allogene Therapeutics's market cap has decreased from $2.88B to $247.17M, a decrease of -91.42%. That is a compound annual growth rate of -31.10%.

Market Cap History

Date	Market Cap	% Change
May 13, 2025	247.17M	-44.66%
Dec 31, 2024	446.60M	-17.32%
Dec 29, 2023	540.17M	-40.45%
Dec 30, 2022	907.08M	-57.34%
Dec 31, 2021	2.13B	-39.95%
Dec 31, 2020	3.54B	11.80%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	669.76B
Johnson & Johnson	357.16B
AbbVie	332.08B
Novo Nordisk	291.59B
UnitedHealth Group	282.47B
Abbott Laboratories	224.53B
Novartis AG	209.81B
AstraZeneca	209.59B

Market Cap Rankings